AdvancedLive ClassesActive

Physician & Prescribers Psychedelic-Assisted Therapy | Psychedelic Therapy Training Program | ATMA

An advanced psychedelic-assisted therapy course for physicians and prescribers covering psychedelic medicine, patient suitability, safety, pharmacology, therapeutic applications, and regulatory frameworks in Canada, Australia, and the United States. The program includes self-paced video lessons, live Q&A sessions, and

Provider

Atma Journey

English

Schedule

Dates not announced

11 hours

Enrollment

$1,897

Decision Summary

Best fit
Physicians and prescribers seeking advanced knowledge of psychedelic medicine and psychedelic-assisted therapy.
Format
Live Classes
Time commitment
11 hours
Credential signal
CME

Course Overview

ATMA’s Physicians & Prescribers Psychedelic-assisted Therapy Course is designed for practitioners seeking advanced knowledge of psychedelic medicine. It examines contemporary and Indigenous histories, current research, therapeutic applications, pharmacology, drug interactions, adverse events, and evolving regulatory frameworks across Canada, Australia, and the United States. The course focuses on assessing patient suitability, inclusion and exclusion criteria, dosing principles, safety, collaborative care, and access through Canada’s Special Access Program. It also addresses inclusion and access challenges affecting marginalized populations, including LGBTQIA+ and BIPOC communities. The program includes 9 modules of pre-recorded lectures, monthly live Q&A sessions, lifetime access to learning materials and industry updates, an online practitioner community, and 11 optional live online self-care sessions with recordings. The listed course duration is 20 hours, with an additional 11 hours for the optional self-care sessions.

Who is this for?

Physicians and prescribers seeking advanced knowledge of psychedelic medicine and psychedelic-assisted therapy.

About the Provider

ATMA Journey Centers is an Alberta-based Canadian pioneer in psychedelic-assisted therapy, operating clinically supervised locations across Canada while offering comprehensive psychedelic-assisted therapy training programs (ATMA CENA) covering psilocybin, MDMA, and ketamine for healthcare professionals. With 740+ training alumni and 800+ community members, ATMA also operates a clinic network partnership program and Phase II psilocybin clinical trials with Health Canada approval.

View all Atma Journey courses

Course FAQ

Who is this course for?

Physicians and prescribers seeking advanced knowledge of psychedelic medicine and psychedelic-assisted therapy.

What is the format and time commitment?

Format: Live Classes. Time commitment: 11 hours.

How much does it cost?

The listed price is $1,897. Confirm the latest tuition, fees, and payment options on the provider website.

Does it offer a certificate or CE/CME credit?

Accreditation note: CME. Confirm credential eligibility directly with the provider before enrolling.

Are dates currently announced?

This active course does not have a listed upcoming cohort date yet. Check the provider website for current schedule details.

Is this course currently available?

The current listing status is Active. Use the provider website for the latest enrollment status.

Related Courses

View all courses